Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

302.50 +1.18 (+0.39%)
Official Closing Price Updated: 4:03 PM EDT, Aug 8, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Summer Stock Market Rally?
While history does not repeat itself it often rhymes. Summer Stock Market rally 2022 is becoming a reality but don’t be enamored by this rally, for unless the trajectory changes dramatically, it will... 
Via Talk Markets
7 Best Pharmaceutical Stocks to Buy Now
These investments represent the best pharmaceutical stocks. Each offers incredible upside potential in the post-pandemic world. 
Via InvestorPlace
Analyzing Eli Lilly's Short Interest
Eli Lilly's (NYSE:LLY) short percent of float has risen 14.81% since its last report. The company recently reported that it has 4.93 million shares sold short, which is 0.62% of... 
Via Benzinga
These Biotechs Are Reportedly Reinvigorating Alzheimer's Disease Research With Novel Drugs That Push Beyond Traditional Approaches
More than 55 million people worldwide have dementia — with about 60% to 70% of those cases resulting from Alzheimer’s disease — and that number is expected to triple by 2050. 
Via Benzinga
Recession-Proof Stock Of The Week: Eli Lilly
Few sectors can withstand the economic headwinds that come during periods of economic upheaval, including recession and inflation. Recession stocks are sought out by retail and institutional investors... 
Via Talk Markets
What 8 Analyst Ratings Have To Say About Eli Lilly
Analysts have provided the following ratings for Eli Lilly (NYSE:LLY) within the last quarter: 
Via Benzinga
BMO Sees 'Differentiated Gene Editing Platform' For This Small-Cap Stock
 
Via Benzinga
Accenture And 3 Other Stocks Insiders Are Selling
Johnson & Johnson (NYSE: JNJ) reported upbeat earnings for its second quarter, but lowered its FY22 guidance. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Week In Review: Qiming Closes $3.2 Billion For China Healthcare And Technology Investments
Qiming Venture Partners closed two new China healthcare and technology funds with $3.2 billion in fresh capital, both of them at their hard cap limits. The USD Fund VIII has $2.5 billion and the first... 
Via Talk Markets
$1000 Invested In This Stock 10 Years Ago Would Be Worth $7,400 Today
Eli Lilly (NYSE:LLY) has outperformed the market over the past 10 years by 11.39% on an annualized basis producing an average annual return of 22.03%. Currently, Eli Lilly has a market capitalization... 
Via Benzinga
Is Merck Stock A Buy Amid Reports It Could Buy Seagen For $40 Billion?
Is Merck stock a buy as reports suggest it could put up $40 billion to acquire Seagen? Is MRK stock a buy right now? 
Via Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
This Analyst Cuts Price Target On Microsoft; Here's The Biggest Price Target Changes For Thursday
Truist Securities cut Criteo S.A. (NASDAQ: CRTO) price target from $40 to $35. Criteo shares fell 3.5% to close at $22.92 on Wednesday. 
Via Benzinga
This Is What Whales Are Betting On Eli Lilly
Someone with a lot of money to spend has taken a bullish stance on Eli Lilly (NYSE:LLY). And retail traders should know. We noticed this today when the big position showed up on publicly available... 
Via Benzinga
Week In Review: Henlius Signs $196 Million Deal For Two Oncology Bifunctional Sialidase Candidates
Shanghai Henlius Biotech acquired Greater China rights to two early-stage bifunctional sialidase candidates from Palleon Pharma, a Waltham, MA biopharma, in a deal with $196.5 million in development... 
Via Talk Markets
What Are Whales Doing With Eli Lilly
A whale with a lot of money to spend has taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli Lilly (NYSE:LLY) we detected 14 strange trades. 
Via Benzinga
If You Invested $100 In This Stock 5 Years Ago, You Would Have $400 Today
Eli Lilly (NYSE:LLY) has outperformed the market over the past 5 years by 21.93% on an annualized basis producing an average annual return of 31.32%. Currently, Eli Lilly has a market capitalization of... 
Via Benzinga
Sanofi Lowers Out-Of-Pocket Insulin Cost For Uninsured Patients
 
Via Benzinga
The Daily Biotech Pulse: Eli Lilly Modifies COVID-19 Treatment Pact, Oyster Point Outlines Restructuring Plan, Icosavax Posts Interim RSV Vaccine Data
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
5 S&P 500 Stocks Ready to Break Out
Although Wall Street is hurting right now, not all S&P 500 stocks are getting thrashed. And these beauties are getting ready to break out. 
Via InvestorPlace
Check Out What Whales Are Doing With LLY
Someone with a lot of money to spend has taken a bearish stance on Eli Lilly (NYSE:LLY). And retail traders should know. We noticed this today when the big position showed up on publicly available... 
Via Benzinga
7 Defensive Stocks to Buy for a Bear Market
As Wall Street gets ready for another earnings season, investors are increasingly chasing after defensive stocks to buy for a bear market. 
Via InvestorPlace
From Axcella To Tonix, Here Are The Penny Stocks Of Companies Working On Long Covid
More than four in 10 people in a recent survey knew of someone with long Covid. 
Via Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Executives Sell More Than $67M Of 5 Stocks: NetApp, Eli Lilly And More
US gold futures traded lower on Friday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
This Is What Whales Are Betting On Eli Lilly
A whale with a lot of money to spend has taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli Lilly (NYSE:LLY) we detected 17 strange trades. 
Via Benzinga
Bear Market Rally Lifts HealthCare Stocks Off Bottom
Clearly we are in a biotech bear market with both diagnostics and vaccine revenues stalled. If gene editing stocks cannot offer breakthrough clinical news then stick with large cap biopharma. 
Via Talk Markets
Peering Into Eli Lilly's Recent Short Interest
Eli Lilly's (NYSE:LLY) short percent of float has risen 4.76% since its last report. The company recently reported that it has 5.23 million shares sold short, which is 0.66% of... 
Via Benzinga
Jim Cramer Says This Company Is A Great One
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Woodside Energy Group Ltd (NYSE: WDS) is a great company, with a great yield. 
Via Benzinga
Approval Of Baricitinib For Patchy Baldness Validates Clinical Patch For This Small-Cap Stock
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.